India-focused private equity firm ChrysCapital has reportedly invested INR3 billion (approximately US$56.2 million) in pharmaceutical company Intas Pharmaceuticals, increasing its existing stake of 11.2 percent to over 15 percent. With the recent investment in place, Intas has deferred its plans to file an initial public offering and intends to re-file once the company believes market conditions have become less volatile. ChrysCapital, which originally invested in the company in 2005, made its most recent investment through its ChrysCapital V fund.